MeSH Browser

MeSH Heading: Bleomycin
Tree Number(s): D09.400.420.110; D12.644.233.110
Unique ID: D001761
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D001761
Annotation: a glycopeptide antineoplastic antibiotic
Scope Note: A complex of related glycopeptide antibiotics from Streptomyces verticillus consisting of bleomycin A2 and B2. It inhibits DNA metabolism and is used as an antineoplastic, especially for solid tumors.
Entry Term(s): BLEO-cell; Blanoxan; Blenoxane; Bleolem; Bleomicina; Bleomycin A(2); Bleomycin A2; Bleomycin B(2); Bleomycin B2; Bleomycin Sulfate; Bleomycins; Bleomycinum Mack; Bléomycine Bellon
Pharm Action: Antibiotics, Antineoplastic
Registry Numbers: 11056-06-7; M62KK37O40; 9041-93-4; 0; 13M89UEA7W
Related Numbers: 13M89UEA7W; 9041-93-4; M62KK37O40
NLM Classification #: QV 269
Previous Indexing: Antibiotics, Antineoplastic (1967-1970)
Public MeSH Note: 96; was BLEOMYCINS 1981-95, was BLEOMYCIN 1974-80
History Note: 96; was BLEOMYCINS 1981-95, was BLEOMYCIN 1972-80 (Prov 1972-73)
Date Established: 1974/01/01
Date of Entry: 1999/01/01
Revision Date: 2016/07/05

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

analysis (AN)

antagonists & inhibitors (AI)

biosynthesis (BI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Bleomycin MeSH Descriptor Data 2025